Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Return on Capital Employed (2020 - 2025)

Beam Therapeutics (BEAM) has disclosed Return on Capital Employed for 6 consecutive years, with 0.01% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed rose 42.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 42.0% year-over-year, with the annual reading at 0.01% for FY2025, 36.0% up from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.01% at Beam Therapeutics, up from 0.4% in the prior quarter.
  • The five-year high for Return on Capital Employed was 0.01% in Q4 2025, with the low at 0.65% in Q1 2021.
  • Average Return on Capital Employed over 5 years is 0.31%, with a median of 0.33% recorded in 2023.
  • The sharpest move saw Return on Capital Employed surged 43bps in 2022, then fell -28bps in 2024.
  • Over 5 years, Return on Capital Employed stood at 0.36% in 2021, then grew by 15bps to 0.3% in 2022, then soared by 50bps to 0.15% in 2023, then plummeted by -188bps to 0.43% in 2024, then surged by 97bps to 0.01% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.01%, 0.4%, and 0.36% for Q4 2025, Q3 2025, and Q2 2025 respectively.